Breast Cancer : the Journal of the Japanese Breast Cancer Society
Overview
Breast Cancer: The Journal of the Japanese Breast Cancer Society is a reputable scientific journal dedicated to advancing knowledge and understanding of breast cancer. It publishes high-quality research articles, reviews, and case studies, covering various aspects of breast cancer, including prevention, diagnosis, treatment, and survivorship. With a focus on the Japanese perspective, this journal serves as a valuable resource for researchers, clinicians, and healthcare professionals involved in breast cancer care and research.
Details
Details
Metrics
Metrics
h-index / Ranks: 5503
66
SJR / Ranks: 3463
1054
CiteScore / Ranks: 4260
5.60
JIF / Ranks: 2264
4.0
Recent Articles
11.
Matsubara Y, Suganuma N, Nakamoto S, Kikawa Y, Iwamoto T, Yamanaka T, et al.
Breast Cancer
. 2025 Feb;
PMID: 39939473
Background: In the realm of surgical therapy for cN0 early breast cancer, sentinel lymph node biopsy (SNB) has been established as a technique that allows the omission of axillary lymph...
12.
Nakayama S, Iwamoto T, Araki K, Narui K, Nakayama T, Nagase H, et al.
Breast Cancer
. 2025 Feb;
PMID: 39928253
Background: The safety of combination therapy with abemaciclib and hormone therapy in patients with hormone receptor-positive (HR +), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (MBC) who...
13.
Hara A, Ozaki A, Murakami M, Saito H, Nashimoto M, Hori D, et al.
Breast Cancer
. 2025 Feb;
PMID: 39921685
Background: Lesbian, gay, bisexual, transgender, and queer (LGBTQ) individuals face significant health disparities worldwide, particularly in preventive medicine. In Japan, where breast cancer has the highest incidence rate among women,...
14.
Nagahashi M, Kumamaru H, Kinukawa N, Iwamoto T, Kawashima M, Kinoshita T, et al.
Breast Cancer
. 2025 Feb;
32(2):217-226.
PMID: 39910023
This is an annual report by the Japanese Breast Cancer Society, which provides statistics on the clinical data on breast cancer in Japan, extracted from the National Clinical Database-Breast Cancer...
15.
Sato K, Fuchikami H, Takeda N, Natsume N, Kato M
Breast Cancer
. 2025 Feb;
32(2):447-455.
PMID: 39907906
Purpose: Multicatheter interstitial brachytherapy (MIB) is an established technique of partial breast irradiation (PBI). However, postoperative catheter implant is an invasive, inconvenient, and skillful procedure. In this study, local control...
16.
Tokunaga E, Koi Y, Tajiri W, Koga C, Ijichi H, Akiyoshi S, et al.
Breast Cancer
. 2025 Feb;
32(2):426-433.
PMID: 39893610
Background: Systemic therapy (ST) is essential for de novo stage IV breast cancer (BC). Stage IV BCs are highly heterogeneous, and it seems inappropriate to treat all de novo stage...
17.
Park M, Cho E, Youn Y, Do I, Woo H, Park H, et al.
Breast Cancer
. 2025 Jan;
32(2):416-425.
PMID: 39890753
Background: Circulating tumor DNA (ctDNA) enables non-invasive evaluation and is considered a promising tool for diagnosis, treatment selection, risk stratification, and disease monitoring. However, while the utility of ctDNA has...
18.
Onder T, Karacin C
Breast Cancer
. 2025 Jan;
32(2):434-446.
PMID: 39888484
Aims And Objectives: Appropriately timed cessation of systemic anticancer treatments is an important part of a patient's quality of life (QoL). We aimed to determine the right time to discontinue...
19.
20.
Farhat J, Sakai H, Tsurutani J
Breast Cancer
. 2025 Jan;
32(2):278-285.
PMID: 39878905
Antibody-drug conjugates (ADCs) are an emerging class of anticancer therapy that combines the specificity and long circulation half-life of monoclonal antibodies with the cytotoxic potency of the payload connected through...